PL2355794T3 - Roztwory substancji lipofilowych, w szczególności roztwory substancji farmaceutycznych - Google Patents

Roztwory substancji lipofilowych, w szczególności roztwory substancji farmaceutycznych

Info

Publication number
PL2355794T3
PL2355794T3 PL09764233T PL09764233T PL2355794T3 PL 2355794 T3 PL2355794 T3 PL 2355794T3 PL 09764233 T PL09764233 T PL 09764233T PL 09764233 T PL09764233 T PL 09764233T PL 2355794 T3 PL2355794 T3 PL 2355794T3
Authority
PL
Poland
Prior art keywords
solution
lipophilic substances
medicinal solutions
especially medicinal
solutions
Prior art date
Application number
PL09764233T
Other languages
English (en)
Inventor
Achim GÖPFERICH
Christoph Luschmann
Original Assignee
Universität Regensburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universität Regensburg filed Critical Universität Regensburg
Publication of PL2355794T3 publication Critical patent/PL2355794T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL09764233T 2008-11-27 2009-11-27 Roztwory substancji lipofilowych, w szczególności roztwory substancji farmaceutycznych PL2355794T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102008059201A DE102008059201A1 (de) 2008-11-27 2008-11-27 In situ präzipitierende Arzneistofflösungen
PCT/EP2009/065982 WO2010060989A1 (de) 2008-11-27 2009-11-27 Lösungen von lipophilen substanzen, insbesondere arzneistofflösungen
EP09764233.4A EP2355794B1 (de) 2008-11-27 2009-11-27 Lösungen von lipophilen substanzen, insbesondere arzneistofflösungen

Publications (1)

Publication Number Publication Date
PL2355794T3 true PL2355794T3 (pl) 2020-04-30

Family

ID=42046252

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09764233T PL2355794T3 (pl) 2008-11-27 2009-11-27 Roztwory substancji lipofilowych, w szczególności roztwory substancji farmaceutycznych

Country Status (8)

Country Link
US (1) US9700509B2 (pl)
EP (1) EP2355794B1 (pl)
CN (1) CN102227210B (pl)
CA (1) CA2743243C (pl)
DE (1) DE102008059201A1 (pl)
ES (1) ES2757800T3 (pl)
PL (1) PL2355794T3 (pl)
WO (1) WO2010060989A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102011108948A1 (de) 2011-07-29 2013-01-31 Achim Göpferich Wässrige, kolloidale Lösungen von lipophilen Substanzen,insbesondere Arzneistofflösungen

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4000263A (en) * 1975-05-02 1976-12-28 Westwood Pharmaceuticals, Inc. Erythromycin solution
SE435332B (sv) 1979-11-07 1984-09-17 Lumalampan Ab Katodenhet for lysror
US5192535A (en) * 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
CH679277A5 (pl) * 1989-02-09 1992-01-31 Sandoz Ag
CA2056032A1 (en) * 1990-11-29 1992-05-30 Minoru Aoki Hard capsule preparation
TW406020B (en) * 1993-09-29 2000-09-21 Bristol Myers Squibb Co Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent
IL111003A0 (en) * 1993-09-30 1994-11-28 American Home Prod Multi-component oral rapamycin formulation
JP4259610B2 (ja) 1994-04-08 2009-04-30 キューエルティー・ユーエスエイ・インコーポレーテッド 液体デリバリー組成物
MX9605131A (es) * 1994-04-28 1997-10-31 Bionumerik Pharmaceutical Inc Formulacion estable de lactona de 7-etil-camptotecina y metodo para usar la misma.
US5817630A (en) * 1997-03-18 1998-10-06 Austin Nutriceutical Corporation Glutathione antioxidant eye drops
GB9717444D0 (en) * 1997-08-19 1997-10-22 Glaxo Group Ltd Pharmaceutical composition
PE20020146A1 (es) * 2000-07-13 2002-03-31 Upjohn Co Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
WO2005065079A2 (en) * 2003-11-10 2005-07-21 Angiotech International Ag Medical implants and fibrosis-inducing agents
DK1848431T3 (en) * 2005-02-09 2016-04-18 Santen Pharmaceutical Co Ltd LIQUID FORMULATIONS FOR TREATMENT OF DISEASES OR CONDITIONS
JP2008543789A (ja) * 2005-06-17 2008-12-04 ホスピラ オーストラリア ピーティーワイ エルティーディー ドセタキセルの液体薬学的処方物
WO2008101344A1 (en) * 2007-02-22 2008-08-28 Peter Tomlinson Soluble bioactive lipophilic compounds compositions

Also Published As

Publication number Publication date
US20110294745A1 (en) 2011-12-01
WO2010060989A1 (de) 2010-06-03
DE102008059201A1 (de) 2010-06-02
CN102227210A (zh) 2011-10-26
HK1159493A1 (en) 2012-08-03
EP2355794A1 (de) 2011-08-17
EP2355794B1 (de) 2019-08-21
CA2743243C (en) 2018-01-02
US9700509B2 (en) 2017-07-11
CA2743243A1 (en) 2010-06-03
ES2757800T3 (es) 2020-04-30
CN102227210B (zh) 2015-01-21

Similar Documents

Publication Publication Date Title
IL207128A0 (en) Pharmaceutical dosage form
IL211314A0 (en) Pharmaceutical dosage forms comprising poly (?á-caprolactone)
AP2010005341A0 (en) Solid pharmaceutical dosage form
ZA201104336B (en) Pharmaceutical compounds
GB0816372D0 (en) Pharmaceutical compounds
GB0820819D0 (en) Pharmaceutical compounds
GB0801416D0 (en) Pharmaceutical compounds
PT2376147T (pt) Recipiente para fármaco melhorado
EP2337835A4 (en) DIFFUSER OF SUBSTANCE
ZA201104348B (en) Pharmaceutical preparation
GB0816371D0 (en) Pharmaceutical compounds
ZA201007107B (en) Film-shaped preparation comprising oily substances for oral administration
ZA200903858B (en) Pharmaceutical dosage form
GB0812969D0 (en) Pharmaceutical compounds
PT2271618E (pt) Compostos farmacêuticos
HU0800591D0 (en) Stable pharmaceutical combination
GB0816370D0 (en) Pharmaceutical compounds
GB0815972D0 (en) Pharmaceutical preparation
GB0803054D0 (en) Medicament
GB0810857D0 (en) Pharmaceutical compounds
IL212603A0 (en) Combined drug administration
IL212409A (en) Pharmacist dispenser
GB0816883D0 (en) Rotary blood pump
IL211062A0 (en) Pharmaceutical uses of lanosta-8,24-dien-3-ols
ZA201108276B (en) Redox drug derivatives